Matches in SemOpenAlex for { <https://semopenalex.org/work/W2581508889> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2581508889 abstract "Abstract The efficacy of Pegfilgrastim (PF) in decreasing the duration of neutropenia has been proved after standard dose of chemotherapy. Results of PF after high dose chemotherapy (HDC) and autologous peripheral blood stem cells transplantation ASCT) are lacking. We studied the efficacy of PG in patients receiving HDC and ASCT for lymphoproliferative disease. Fifteen consecutive patients (8 males; 7 females) were onrolled in the study from September 2003 through March 2004. Median age of the patients was 56 years. Diseases were multiple myeloma in 5 patients, diffuse large cell non-Hodgkin’s lymphoma (NHL) in 3 patients, follicular lymphoma in 4 patients, mantle cell lymphoma in one patient, and primary central nervous system lymphoma PCNSL) in 2 patients. All patients were eligible for HDC and ASCT per institutional criteria. Stem cells were collected with peripheral blood pheresis after high dose cyclophosphamide (7 cases); high dose Ara-c (5 cases); ifosfamide (1 case); CHOP-like chemotherapy (1 case); or in steady state (1 case). All the patients received daily G-CSF (5 to 10 mcg/kg). Three different conditioning regimens were used. Patients with multiple myeloma received high dose melphalan (200 mg/m²), patients with PCNSL received a combination of high dose Thiotepa (750 mg/m²), Busulfan (12 mg/kg), and Cyclophosphamide (120 mg/kg), and patients with NHL received a BEAM chemotherapy. PF was administered as a single subcutaneous injection of 6 mg at day +3 after stem cell infusion, except for one patient whose injection was done on day 4. No adverse event attributable to PF was observed. There were no toxic death on study. All patients engrafted neutrophils and platelets. The median time to neutrophils engraftment (> 500/mm3) was 7 days (range, 4–12). Febrile neutropenia was almost constant (14/15) but never exceed OMS grade 2. Median number of days with IV antibiotics was 7 days (range 5–22). These preliminary data show that a fixed dose of 6 mg of PF given subcutaneously at day +3 after HDC and ASCT is safe and effective. A cost efficacy study is warranted to compare PF and daily dose of standard G-CSF after ASCT." @default.
- W2581508889 created "2017-02-03" @default.
- W2581508889 creator A5001106148 @default.
- W2581508889 creator A5008156284 @default.
- W2581508889 creator A5010583966 @default.
- W2581508889 creator A5030570042 @default.
- W2581508889 creator A5053814096 @default.
- W2581508889 creator A5069367968 @default.
- W2581508889 date "2004-11-16" @default.
- W2581508889 modified "2023-09-30" @default.
- W2581508889 title "Pegfilgrastim after High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cells Transplantation. A Single-Centre Experience in 15 Patients." @default.
- W2581508889 doi "https://doi.org/10.1182/blood.v104.11.4213.4213" @default.
- W2581508889 hasPublicationYear "2004" @default.
- W2581508889 type Work @default.
- W2581508889 sameAs 2581508889 @default.
- W2581508889 citedByCount "4" @default.
- W2581508889 countsByYear W25815088892017 @default.
- W2581508889 crossrefType "journal-article" @default.
- W2581508889 hasAuthorship W2581508889A5001106148 @default.
- W2581508889 hasAuthorship W2581508889A5008156284 @default.
- W2581508889 hasAuthorship W2581508889A5010583966 @default.
- W2581508889 hasAuthorship W2581508889A5030570042 @default.
- W2581508889 hasAuthorship W2581508889A5053814096 @default.
- W2581508889 hasAuthorship W2581508889A5069367968 @default.
- W2581508889 hasConcept C126322002 @default.
- W2581508889 hasConcept C141071460 @default.
- W2581508889 hasConcept C2776364478 @default.
- W2581508889 hasConcept C2776694085 @default.
- W2581508889 hasConcept C2776755627 @default.
- W2581508889 hasConcept C2777058707 @default.
- W2581508889 hasConcept C2777063308 @default.
- W2581508889 hasConcept C2777525834 @default.
- W2581508889 hasConcept C2778658803 @default.
- W2581508889 hasConcept C2778684742 @default.
- W2581508889 hasConcept C2779050716 @default.
- W2581508889 hasConcept C2779171977 @default.
- W2581508889 hasConcept C2779338263 @default.
- W2581508889 hasConcept C2779968505 @default.
- W2581508889 hasConcept C2780611847 @default.
- W2581508889 hasConcept C2911091166 @default.
- W2581508889 hasConcept C71924100 @default.
- W2581508889 hasConcept C90924648 @default.
- W2581508889 hasConceptScore W2581508889C126322002 @default.
- W2581508889 hasConceptScore W2581508889C141071460 @default.
- W2581508889 hasConceptScore W2581508889C2776364478 @default.
- W2581508889 hasConceptScore W2581508889C2776694085 @default.
- W2581508889 hasConceptScore W2581508889C2776755627 @default.
- W2581508889 hasConceptScore W2581508889C2777058707 @default.
- W2581508889 hasConceptScore W2581508889C2777063308 @default.
- W2581508889 hasConceptScore W2581508889C2777525834 @default.
- W2581508889 hasConceptScore W2581508889C2778658803 @default.
- W2581508889 hasConceptScore W2581508889C2778684742 @default.
- W2581508889 hasConceptScore W2581508889C2779050716 @default.
- W2581508889 hasConceptScore W2581508889C2779171977 @default.
- W2581508889 hasConceptScore W2581508889C2779338263 @default.
- W2581508889 hasConceptScore W2581508889C2779968505 @default.
- W2581508889 hasConceptScore W2581508889C2780611847 @default.
- W2581508889 hasConceptScore W2581508889C2911091166 @default.
- W2581508889 hasConceptScore W2581508889C71924100 @default.
- W2581508889 hasConceptScore W2581508889C90924648 @default.
- W2581508889 hasLocation W25815088891 @default.
- W2581508889 hasOpenAccess W2581508889 @default.
- W2581508889 hasPrimaryLocation W25815088891 @default.
- W2581508889 hasRelatedWork W2014921106 @default.
- W2581508889 hasRelatedWork W2075175599 @default.
- W2581508889 hasRelatedWork W2144075794 @default.
- W2581508889 hasRelatedWork W2308450625 @default.
- W2581508889 hasRelatedWork W2397667327 @default.
- W2581508889 hasRelatedWork W2435256000 @default.
- W2581508889 hasRelatedWork W2581508889 @default.
- W2581508889 hasRelatedWork W2582424465 @default.
- W2581508889 hasRelatedWork W2760331070 @default.
- W2581508889 hasRelatedWork W4293043482 @default.
- W2581508889 isParatext "false" @default.
- W2581508889 isRetracted "false" @default.
- W2581508889 magId "2581508889" @default.
- W2581508889 workType "article" @default.